When and where
Starts: Wednesday, 28 January 2026 - 11:00 (in 0 minutes)
Location:
Xtalks, Toronto, Canada
This event was automatically imported. Click the Source link below to double check the Start time and Location.
Event description
Enrolling the wrong patients is a serious protocol deviation that leads to costly rework and delays, and increases risk to patient safety, data integrity and regulatory approval. The FDA’s December 2024 draft guidance titled “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices” emphasizes a quality by design approach for preventing protocol deviations. Join this webinar to learn how sponsors, CROs and academic research organizations (AROs) can mitigate risk by applying a quality by design framework at a key focus area highlighted by the FDA: eligibility.
Through best practice and case study data, attendees will gain insight into how centralized eligibility review and structured workflows support protocol-compliant enrollment, strengthen documentation and enable faster, more consistent decisions without compromising quality.
Join industry experts as they share practical strategies to prevent enrollment-based deviations, streamline eligibility decisions, ensure data integrity and enhance patient safety.
Register for this webinar to equip patient enrollment teams with practical strategies to prevent protocol deviations, improve eligibility decision-making and reduce downstream operational risk.
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 222
- Comments 0